Parkinson's patients see hope in ADHD drug for gait and focus
NCT ID NCT00914095
First seen May 14, 2026 · Last updated May 14, 2026
Summary
This study tested whether methylphenidate (Ritalin), a drug used for ADHD, could improve walking problems and attention in people with advanced Parkinson's disease. 69 participants with severe gait issues and freezing episodes were given either the drug or a placebo for 3 months. The goal was to see if the drug could make walking easier and boost attention without major side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEMENTIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Service de Neurologie, Clinique Neurologique, EA 2683, IFR 114
Lille, 59037, France
Conditions
Explore the condition pages connected to this study.